| Suggest |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Politics > Justice in Cameroon |
|
Suggest - Justice in Cameroon
Obviously, everyone will find coincidence all the more strange as the ambassador of the United According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product States from America in Yaounde, that there even which had engaged the process during an extre ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in mely mediatized public statement last month, went, at the moment when these media of State tri lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ed to deny the obviousness, to thank the Head of the State... for having respected its promise here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he ensuring of its support for the actions to come and... highly waited. It is obviously hea d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lthier for our country of knowing than certain measurements can be taken to ensure, at least i ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc n the future, fear of the forces of law and order and most importantly the guarantee of a har easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi onious and balanced development. the apperance in courts of some managers of suspected fraud a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nd embezlement of public funds public are already being sanctioned . the population, crushed b and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y poverty and the "badly-life", is avid of blood to comfort its misfortunes. how can allow hi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi , in this era of legal uncertainty, to designate from now on its culprits. Because if, day aft ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a er day, old big shots of the mode can pass from a soft breakfast with their offspring to one dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod night at the bottom of a dungeon, without bed linen to draw up a summary layer, who will be wi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin th the shelter in this fauna of characters more or less graded of the system of Paul Biya? Re tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ain that there is nevertheless like a faintness, like an error of taste, to observe that, once t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel again, the initiative of what resembles a social storm, was still taken by the omnipotent one ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and the omniscient president of the Republic, man with all to decide, with rythmer tempo, in y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products country presented (undoubtedly wrongly) under its republican tradition, with inter alia compo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nents essential so expensive in Montesquieu, the separation of the capacities between the Exec elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip utive, the Legislature and the Legal one, all devoted by the fundamental law, the Constitution tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Paris Hilton? Your Online Marketing Fails Because You Market As If You Were Ms Hilton Four Common Mistakes Made Using Web Templates House to Recess After Two Major Tax Bills Pass
|